The comparison of remimazolam and propofol for pediatric gastroscopy sedation: a single center random control study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100041686

Enrollment

Unknown

Registered

2021-01-01

Start date

2021-01-15

Completion date

Unknown

Last updated

2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Gastroscopy

Interventions

1:remimazolam

2:propofol

Eligibility

Sex/Gender

All

Age

4 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Aged 4-12 years; 2. ASA I-III; 3. undergong gastroscopy.

Exclusion criteria

Exclusion criteria: 1. History of adverse events of sedation or anesthesia; 2. allergy to study related medicine; 3. upper respiratory airway infection within 2 weeks. cardiopulmonary compromise.

Design outcomes

Primary

Measure	Time frame
the success rate of Gastroscopy;	—

Secondary

Measure	Time frame
the incidence of adverse events during induction;the incidence of adverse events during procedural;the incidence of adverse events during PACU;the incidence of adverse events within 24 hours;	—

Countries

China

Contacts

Public ContactHuang Lei

Kunming Children's Hospital

65255106@etyy.cn+86 18087347480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026